JP Morgan Maintains Overweight on Mobia Medical, Raises Price Target to $17
JP Morgan analyst Robbie Marcus maintains Mobia Medical (NASDAQ:MOBI) with a Overweight and raises the price target from $15 to $17.
Read original at benzingaStocks · News reference
8-K filing — Mobia Medical, Inc. (MOBI)
Filed: 2026-08-03 AccNo: 0001193125-26-330853 Size: 158 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 3, 2026, 9:20 PM
- Checked
- Aug 3, 2026, 9:20 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
BTIG Reiterates Buy on Mobia Medical, Maintains $19 Price Target
BTIG analyst Ryan Zimmerman reiterates Mobia Medical (NASDAQ:MOBI) with a Buy and maintains $19 price target.
Read original at benzingaMobia Medical Sees FY2026 Sales $54.000M-$56.000M vs $53.504M Est
Mobia Medical (NASDAQ:MOBI) sees FY2026 sales of $54.000 million-$56.000 million vs $53.504 million analyst estimate.
Read original at benzingaMobia Medical Q2 EPS $(1.10) Misses $(0.82) Estimate, Sales $13.505M Beat $12.380M Estimate
Mobia Medical (NASDAQ:MOBI) reported quarterly losses of $(1.10) per share which missed the analyst consensus estimate of $(0.82) by 34.15 percent. The company reported quarterly sales of $13.505 million which beat the
Read original at benzinga